Validation of a Size-Exclusion LC Method and Assessment of rhEPO in Pharmaceutical Formulations by Liquid Chromatography and Biological Assay

REFERENCES

• RamaKrishnan , R. ; Cheung , W.K. ; Wacholtz , M.C. ; Minton , N. ; Jusko , W.J. Pharmacokinetic and pharmacodynamic modeling of recombinant human erytropoietin after single and multiple doses in healthy volunteers . J. Clin. Pharmacol. 2004 , 44 , 991 – 1002 .
   PubMed Web of Science ®Google Scholar
• Gascón , P. Evaluating erythropoietic agents for the treatment of anaemia in the oncology setting. Eur. J. Cancer 2005, 41, 2601–2612.
   PubMed Web of Science ®Google Scholar
• Ruifrok , W.T. ; Boer , R.A. ; Westenbrink , B.D. ; van Veldhuisen , D.J. ; vsn Gilst , W.H. Erythropoietin in cardiac disease: New features of an old drug . Eur. J. Pharmacol. 2008 , 585 , 270 – 277 .
   PubMed Web of Science ®Google Scholar
• Krantz , S.B. Erythropoetin . Blood 1991 , 77 , 419 – 434 .
   PubMed Web of Science ®Google Scholar
• Elliot , S. ; Egrie , J. ; Browne , J. ; Lorenzini , T. ; Busse , L. ; Rogers , N. ; Ponting , I. Control of rhuEPO biological activity: The role of carbohydrate . Exp. Hematol. 2004 , 32 , 1146 – 1155 .
   PubMed Web of Science ®Google Scholar
• Parnham , M.J. ; Schindler-Horvat , J. ; Kozlovic , M. Non-Clinical Safety Studies on Biosimilar Recombinant Human Erythropoietin . Basic Clin. Pharm. Toxic. 2007 , 100 , 73 – 83 .
   PubMed Web of Science ®Google Scholar
• Storring , P.L. ; Gaines Das , R.E. The international standard for recombinant DNA-derived erythropoietin: collaborative study of four recombinant DNA-derived erythropoietins and two highly purified human urinary erythropoetins . J. Endocrinol. 1992 , 134 , 459 – 484 .
   PubMed Web of Science ®Google Scholar
• Bristow , A. III Collaborative study for the establishment of a biological reference preparation for erythropoietin . Pharmeuropa 1997 , 2 , 31 – 47 .
   Google Scholar
• Liefooghe , E.C. ; Tiplady , R. ; Gerson , P. ; Lloyd , P. ; Heath , A. ; Bristow , A.F. A sialylation-sensitive cell-based in vitro bioassay for erythropoietin; incorporation of the galactose-binding Erythrina crista-galli lectin . Biologicals 2005 , 33 , 161 – 167 .
   PubMed Web of Science ®Google Scholar
• Ramos , A.S. ; Schmidt , C.A. ; Andrade , S.S. ; Fronza , M. ; Rafferty , B. ; Dalmora , S.L. Biological evaluation of recombinant human erythropoietin in pharmaceutical products . Braz. J. Med. Biol. Res. 2003 , 36 , 1561 – 1569 .
   PubMed Web of Science ®Google Scholar
• Barth , T. ; Oliveira , P.R. ; D'Avila , F.B. ; Dalmora , S.L. Validation of the normocythaemic mice bioassay for the potency assessment of recombinant human erythropoietin in pharmaceutical formulations . J. AOAC Intl. 2008 , 91 , 285 – 291 .
   Google Scholar
• EUROPEAN Pharmacopoeia, , 6th ed.; Council of Europe : Strasbourg , 2008 .
   Google Scholar
• Wang , W. Instability, stabilization, and formulation of liquid protein pharmaceuticals . Intl. J. Pharm. 1999 , 185 , 129 – 188 .
   PubMed Web of Science ®Google Scholar
• Longstaff , C. ; Whitton , C.M. ; Stebbings , R. ; Gray , E. How to assure the quality of biological medicines . Drug Discov. Today 2009 , 14, 50–55.
   Google Scholar
• Bietlot , H.P. ; Girard , M. Analysis of recombinant human erythropoietin in drug formulations by high-performance capillary electrophoresis . J. Chromatogr. A 1997 , 759 , 177 – 184 .
   PubMed Web of Science ®Google Scholar
• Lara-Quintanar , P. ; Lacunza , I. ; Sanz , J. ; Diez-Masa , J.C. ; de Frutos , M. Immunochromatographic removal of albumin in erythropoietin biopharmaceutical formulations for its analysis by capillary electrophoresis . J. Chromatogr. A 2007 , 1153 , 227 – 234 .
   Google Scholar
• Barth , T. ; Sangoi , M.S. ; Silva , L.M. ; Ferretto , R.M. ; Dalmora , S.L. Assessment of rhEPO in pharmaceutical formulations by a reversed-phase liquid chromatography method and bioassay . J. Liq. Chromatogr. & Rel. Technol. 2007 , 30 , 1277 – 1288 .
   Web of Science ®Google Scholar
• Gunturi , S.R. ; Ghobrial , I. ; Sharma , B. Development of a sensitive size exclusion HPLC method with fluorescence detection for the quantitation of recombinant human erythropoietin r-HuEPO aggregates. J. Pharm. Biomed. Anal. 2007, 43, 213–221.
   PubMed Web of Science ®Google Scholar
• Luykx , D.M.A.M. ; Dingemanse , P.J. ; Goerdayal , S.S. ; Jongen , P.M.J.M. High-performance anion-exchange chromatography combined with intrinsic fluorescence detection to determine erythropoietin in pharmaceutical products . J. Chromatogr. A 2005 , 1078 , 113 – 119 .
   PubMed Web of Science ®Google Scholar
• ICH – International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for human use: Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals. 1997.
   Google Scholar
• Injac , R. ; Boskovic , M. ; Kocevar , N. ; Vovk , T. Comparative study of robustness between micellar electrokinetic capillary chromatography and high-performance liquid chromatography using one-variable-at-a-time and a new multi-variable-at-a-time approach . Anal. Chim. Acta 2008 , 620 , 150 – 161 .
   Web of Science ®Google Scholar
• Dejaegher , B. ; Heyden , Y.V. Ruggedness and robustness testing . J. Chromatogr. A 2007 , 1158 , 138 – 157 .
   PubMed Web of Science ®Google Scholar